David E Malarkey Selected Research

David E Malarkey Research Topics

Disease

20	Neoplasms (Cancer) 01/2021 - 05/2004
4	Carcinoma (Carcinomatosis) 01/2016 - 02/2006
4	Carcinogenesis 01/2014 - 01/2005
3	Body Weight (Weight, Body) 10/2020 - 01/2002
3	Inflammation (Inflammations) 09/2014 - 12/2004
3	Adenoma (Adenomas) 01/2014 - 01/2009
3	Hemangiosarcoma (Angiosarcoma) 07/2013 - 11/2002
2	Neoplasm Metastasis (Metastasis) 01/2016 - 01/2005
2	Hypoxia (Hypoxemia) 02/2006 - 11/2002
1	Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic) 01/2021
1	Glioma (Gliomas) 01/2021
1	Hypertrophy 10/2020
1	Liver Diseases (Liver Disease) 10/2020
1	Leiomyoma (Uterine Fibroids) 01/2019
1	Leiomyosarcoma 01/2019
1	Cysts 01/2018
1	Hyperplasia 10/2017
1	Cardiomyopathies (Cardiomyopathy) 01/2016
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2016
1	Neurocytoma 01/2016
1	Non-alcoholic Fatty Liver Disease 09/2014
1	Obesity 09/2014
1	Carcinosarcoma 01/2014
1	Poisoning 01/2014
1	Hepatoblastoma 01/2014
1	Endometrial Hyperplasia 01/2014
1	Hypercalcemia (Milk Alkali Syndrome) 01/2014
1	Hemangioma (Angioma) 07/2013
1	Lipidoses 06/2012
1	Intestinal Lymphangiectasis 06/2012
1	Leukemia 09/2011
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2010
1	Chloracne 11/2009
1	Hypochromic Anemia (Chlorosis) 05/2009
1	Infections 10/2008
1	Fibrosarcoma 12/2007
1	Type 2 Diabetes Mellitus (MODY) 12/2007
1	Liposarcoma 12/2007
1	Insulin Resistance 12/2007
1	Meningioma (Meningiomas) 10/2007

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2004
4	Formaldehyde (Formol)FDA Link 01/2021 - 05/2004
4	ParaffinIBA 01/2021 - 05/2004
3	CarcinogensIBA 01/2016 - 10/2007
2	3,4,3',4'-tetrachloroazobenzeneIBA 01/2014 - 11/2009
2	AntigensIBA 07/2013 - 01/2002
2	Drinking WaterIBA 12/2011 - 01/2009
2	DNA (Deoxyribonucleic Acid)IBA 04/2007 - 11/2002
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2021
1	Flame Retardants (Fire Retardants)IBA 10/2020
1	Corn Oil (Oil, Corn)IBA 10/2020
1	2,2',4,4'-tetrabromodiphenyl etherIBA 10/2020
1	DesminIBA 01/2019
1	Estrogen ReceptorsIBA 01/2018
1	Keratin-18 (Keratin 18)IBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	4-ethyltoluene (p-ethyltoluene)IBA 10/2017
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 09/2014
1	Persistent Organic PollutantsIBA 09/2014
1	Polychlorinated Biphenyls (PCBs)IBA 09/2014
1	XenobioticsIBA 09/2014
1	aroclor 1260IBA 09/2014
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 09/2014
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2014
1	CytosineIBA 01/2014
1	GuanineIBA 01/2014
1	Mutant Proteins (Protein, Mutant)IBA 01/2014
1	Uroplakin IIIIBA 01/2014
1	melamineIBA 01/2014
1	von Willebrand FactorIBA 07/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2013
1	OsteonectinIBA 06/2012
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 06/2012
1	indole-3-carbinolIBA 06/2012
1	CateninsIBA 06/2012
1	SERPIN-B5 (maspin)IBA 06/2012
1	Cyclin D1IBA 06/2012
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2012
1	Aflatoxin B1 (Aflatoxin B)IBA 05/2012
1	Protein Isoforms (Isoforms)IBA 04/2012
1	LipidsIBA 04/2012
1	Androstenedione (4 Androstene 3,17 dione)IBA 09/2011
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2010
1	DioxinsIBA 11/2009
1	chromium hexavalent ionIBA 05/2009
1	Dichloroacetic AcidIBA 01/2009
1	triethanolamineIBA 10/2008
1	TeaIBA 10/2008
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2007
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 10/2007
1	Cyclin-Dependent Kinase Inhibitor p16IBA 10/2007
1	Reverse Transcriptase InhibitorsIBA 04/2007
1	NucleosidesIBA 04/2007
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 04/2007
1	Zidovudine (Retrovir)FDA LinkGeneric 04/2007
1	CCI 103FIBA 02/2006
1	pimonidazoleIBA 02/2006

Therapy/Procedure

4	Therapeutics 01/2021 - 05/2004